These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Direct measurement of propranolol bioavailability during accumulation to steady-state. Wood AJ; Carr K; Vestal RE; Belcher S; Wilkinson GR; Shand DG Br J Clin Pharmacol; 1978 Oct; 6(4):345-50. PubMed ID: 698031 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of glucuronidation of propranolol following oral administration in humans. Midha KK; Roscoe RM; Wilson TW; Cooper JK; Loo JC; Ho-Ngoc A; McGilveray IJ Biopharm Drug Dispos; 1983; 4(4):331-8. PubMed ID: 6661512 [TBL] [Abstract][Full Text] [Related]
16. The effect of ageing on the hepatic clearance of propranolol. Castleden CM; George CF Br J Clin Pharmacol; 1979 Jan; 7(1):49-54. PubMed ID: 760742 [TBL] [Abstract][Full Text] [Related]
17. Increased clearance of propranolol and theophylline by high-protein compared with high-carbohydrate diet. Fagan TC; Walle T; Oexmann MJ; Walle UK; Bai SA; Gaffney TE Clin Pharmacol Ther; 1987 Apr; 41(4):402-6. PubMed ID: 3829577 [TBL] [Abstract][Full Text] [Related]
18. Kinetics and cardiac effects of propranolol in humans. Ochs HR; Grube E; Greenblatt DJ; Knüchel M; Bodem G Klin Wochenschr; 1982 May; 60(10):521-5. PubMed ID: 7098380 [TBL] [Abstract][Full Text] [Related]
19. Influence of food on the intravenous and oral dose kinetics of propranolol in the dog. Bai SA; Walle UK; Walle T J Pharmacokinet Biopharm; 1985 Jun; 13(3):229-41. PubMed ID: 4087163 [TBL] [Abstract][Full Text] [Related]